VITALE, FILIPPO
 Distribuzione geografica
Continente #
NA - Nord America 99
AS - Asia 52
EU - Europa 51
SA - Sud America 9
Continente sconosciuto - Info sul continente non disponibili 7
AF - Africa 1
Totale 219
Nazione #
US - Stati Uniti d'America 95
IT - Italia 21
SG - Singapore 19
RU - Federazione Russa 16
CN - Cina 10
BD - Bangladesh 7
BR - Brasile 6
VN - Vietnam 6
DE - Germania 5
HK - Hong Kong 4
AR - Argentina 3
CA - Canada 3
GB - Regno Unito 3
FI - Finlandia 2
IN - India 2
JP - Giappone 2
UA - Ucraina 2
DZ - Algeria 1
FR - Francia 1
GR - Grecia 1
NI - Nicaragua 1
TR - Turchia 1
UZ - Uzbekistan 1
Totale 212
Città #
San Jose 19
Council Bluffs 16
Ashburn 11
Singapore 9
Naples 5
Moscow 4
Beijing 3
Hong Kong 3
Los Angeles 3
Santa Clara 3
Boardman 2
Dallas 2
Ho Chi Minh City 2
Munich 2
New York 2
Shanghai 2
Tokyo 2
Toronto 2
Turku 2
Angri 1
Athens 1
Balneário Arroio do Silva 1
Bari 1
Belen de Escobar 1
Benevento 1
Bengaluru 1
Bowie 1
Brooklyn 1
Charleston 1
Charlotte 1
Cuiabá 1
Da Nang 1
Darby 1
Denver 1
Düsseldorf 1
Everett 1
Falkenstein 1
Figino 1
Formosa 1
Frankfurt am Main 1
Hanoi 1
Hillsboro 1
Itu 1
Jackson 1
Jacksonville 1
Kochi 1
Konya 1
Laredo 1
Lauterbourg 1
Lavras 1
Liverpool 1
Lomas de Zamora 1
London 1
Managua 1
Orem 1
Orlando 1
Piscataway 1
Porto Alegre 1
Racine 1
Rio Brilhante 1
Riverdale 1
Riverside 1
Rochdale 1
Rome 1
Secaucus 1
Selma 1
Spring Valley 1
Tashkent 1
Tlemcen 1
Verona 1
Warwick 1
Washington 1
Zephyrhills 1
Totale 148
Nome #
Blinded independent central review versus local investigator assessment of PFS in RCTs of immunotherapy in advanced cancers: A systematic review and meta-analysis 135
Censoring in trials testing immunotherapy in advanced cancers: a systematic review and a meta-research study 22
Performance of Control Arms in Trials Leading to FDA Cancer Drug Approvals 20
Quality of life results and survival outcomes in trials of immunotherapy in advanced cancers: A systematic review and meta-research study 18
Epigenetic modifiers to enhance the efficacy of immune checkpoint inhibitors for the treatment of melanoma 13
Correlation of ORR and PFS with OS outcomes in phase III trials of immunotherapy in advanced NSCLC: Systematic review and meta-analysis 11
Totale 219
Categoria #
all - tutte 897
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 897


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/202535 0 0 0 0 0 0 4 2 4 6 14 5
2025/2026114 4 3 11 3 11 5 5 3 11 8 15 35
2026/202770 15 16 14 25 0 0 0 0 0 0 0 0
Totale 219